Global Infectious Disease Therapeutics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Infectious Disease Therapeutics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Infectious Disease Therapeutics market finds that the global Infectious Disease Therapeutics market reached a value of USD 200008.72 million in 2022. It’s expected that the market will achieve USD 279468.87 million by 2028, exhibiting a CAGR of 5.73% during the forecast period.

Key Companies in the global Infectious Disease Therapeutics market covered in Chapter 3:

F. Hoffmann-La Roche Ltd.
Janssen Pharmaceutical Inc.
Novartis AG
Merck and Co. Inc.
BioCryst Pharmaceuticals Inc.
GlaxoSmithKline plc
Gilead
Boehringer Ingelheim GmbH

In Chapter 4 and Chapter 14.2, on the basis of types, the Infectious Disease Therapeutics market from 2018 to 2029 is primarily split into:

Drugs
Vaccines

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Infectious Disease Therapeutics market from 2018 to 2029 covers:

HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)